Psychostimulant medication approved in the United States for treatment of narcolepsy (marketed as Provigil); investigational for other uses. Modafinil is less likely to cause jitteriness, anxiety, excess locomotor activity, or a hypersomnolent 'rebound effect' than the amphetamines.